Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
45 hedge funds and large institutions have $169M invested in Akoya BioSciences in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 9 closing their positions.
188% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 8
37% more capital invested
Capital invested by funds: $124M → $169M (+$45.8M)
5.96% more ownership
Funds ownership: 26.65% → 32.62% (+6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 47 → 45 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$22.4M |
| 2 |
HEC
Hudson Executive Capital
New York
|
+$7.23M |
| 3 |
BlackRock
New York
|
+$4.66M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.28M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$3.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$8.09M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$4.26M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.12M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.68M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.99M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCM
51
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$209K | -15,000 | Closed |
|
52
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$191K | -13,723 | Closed |
|
|
PPA
53
Parametric Portfolio Associates
Seattle,
Washington
| – | -$154K | -11,031 | Closed |
|
54
SG Americas Securities
New York
| – | -$122K | -8,713 | Closed |
|
AKYA Hedge Fund Activity: Q4 2021 in Review
45 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q4 2021, worth a combined $169M — up 37% from $124M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AKYA and 7 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 23 added.
The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $22.4M. The largest seller was Board of Trustees of The Leland Stanford Junior University, cutting an estimated $8.09M.
- 45 institutional investors held Akoya BioSciences (AKYA) as of Q4 2021, down from 47 in Q3 2021.
- Funds reported $169M of Akoya BioSciences stock for Q4 2021, up 37% quarter-over-quarter.
- 7 funds opened new Akoya BioSciences positions in Q4 2021 and 9 closed out, a net change of -2 holders.
- The largest Akoya BioSciences buyer in Q4 2021 was Blue Water Life Science Advisors, an estimated $22.4M added.
- The largest Akoya BioSciences seller in Q4 2021 was Board of Trustees of The Leland Stanford Junior University, an estimated $8.09M sold.
Based on aggregated 13F filings for Q4 2021.